ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
failure to respond or late response
on 29 Nov 2023
Last Applicant/ Owned by
140 First Street, Suite 501
Cambridge
MA
02141
Serial Number
97342595 filed on 01st Apr 2022
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
OMEGA THERAPEUTICS
Pharmaceutical agents affecting DNA structure by targeting DNA structure to treat various diseases in the nature of monogenic diseases, cancer, infectious disease, immune disease, hematological conditions, haploinsufficiencies, hepatic disease, channelopathies, endocrine disease, cardiovascular disease, reproductive disease, renal disease, skeletal muscle disease, bone disease, none of the foregoi Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical agents affecting DNA structure by targeting DNA structure to treat various diseases in the nature of monogenic diseases, cancer, infectious disease, immune disease, hematological conditions, haploinsufficiencies, hepatic disease, channelopathies, endocrine disease, cardiovascular disease, reproductive disease, renal disease, skeletal muscle disease, bone disease, none of the foregoing including omega fatty acids
First Use Date in General
31st Jul 2022
First Use Date in Commerce
31st Jul 2022
Mark Details
Serial Number
No 97342595
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 29th Nov 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| 29th Nov 2023 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| 16th Aug 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| 16th Aug 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| 01st Jun 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 01st Jun 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 01st Jun 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 17th May 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| 17th May 2023 | SU - NON-FINAL ACTION - WRITTEN |
| 17th May 2023 | NON-FINAL ACTION E-MAILED |